159 related articles for article (PubMed ID: 32206969)
1. Clinical outcomes and prognostic factors associated with internal ureteral stent placement for malignant extrinsic ureteral obstruction.
Matsuura H; Arase S; Hori Y
Support Care Cancer; 2020 Dec; 28(12):5743-5750. PubMed ID: 32206969
[TBL] [Abstract][Full Text] [Related]
2. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
Matsuura H; Arase S; Hori Y
Int J Clin Oncol; 2019 Mar; 24(3):306-312. PubMed ID: 30298199
[TBL] [Abstract][Full Text] [Related]
3. [The Predictive Factors of Stent Failure in the Treatment of Malignant Extrinsc Ureteral Obstruction Using Internal Ureteral Stents].
Matsuura H; Arase S; Hori Y; Tochigi H
Hinyokika Kiyo; 2017 Dec; 63(12):503-507. PubMed ID: 29370660
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
[TBL] [Abstract][Full Text] [Related]
5. Development of prognostic model for predicting survival after retrograde placement of ureteral stent in advanced gastrointestinal cancer patients and its evaluation by decision curve analysis.
Kawano S; Komai Y; Ishioka J; Sakai Y; Fuse N; Ito M; Kihara K; Saito N
Minerva Urol Nefrol; 2016 Oct; 68(5):437-43. PubMed ID: 26554732
[TBL] [Abstract][Full Text] [Related]
6. Tandem ureteral stents for the decompression of malignant and benign obstructive uropathy.
Elsamra SE; Motato H; Moreira DM; Waingankar N; Friedlander JI; Weiss G; Smith AD; Okeke Z
J Endourol; 2013 Oct; 27(10):1297-302. PubMed ID: 23829600
[TBL] [Abstract][Full Text] [Related]
7. Renal function is associated with prognosis in stent-change therapy for malignant ureteral obstruction.
Yoon JH; Park S; Park S; Moon KH; Cheon SH; Kwon T
Investig Clin Urol; 2018 Nov; 59(6):376-382. PubMed ID: 30402570
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of ureteral stenting for managing extrinsic ureteral obstruction due to gynecological and gastrointestinal cancer].
Takehara K; Onita T; Mochizuki Y; Miyata Y; Igawa T; Sakai H
Hinyokika Kiyo; 2014 Jan; 60(1):13-6. PubMed ID: 24594767
[TBL] [Abstract][Full Text] [Related]
9. Wire-reinforced ureteral stents to rescue from nephrostomy tube in extrinsic ureteral obstruction.
Dauw CA; Faerber GJ; Hollingsworth JM; Wolf JS
Can J Urol; 2015 Jun; 22(3):7806-10. PubMed ID: 26068630
[TBL] [Abstract][Full Text] [Related]
10. Predicting the success of retrograde stenting for managing ureteral obstruction.
Yossepowitch O; Lifshitz DA; Dekel Y; Gross M; Keidar DM; Neuman M; Livne PM; Baniel J
J Urol; 2001 Nov; 166(5):1746-9. PubMed ID: 11586215
[TBL] [Abstract][Full Text] [Related]
11. Early Application of Permanent Metallic Mesh Stent in Substitution for Temporary Polymeric Ureteral Stent Reduces Unnecessary Ureteral Procedures in Patients With Malignant Ureteral Obstruction.
Kim KH; Cho KS; Ham WS; Hong SJ; Han KS
Urology; 2015 Sep; 86(3):459-64. PubMed ID: 26142711
[TBL] [Abstract][Full Text] [Related]
12. Application of resonance metallic stents for malignant ureteral obstruction.
Kang Q; Jiang F; Yu Y; Shen C; Lv H; Yang B
Minim Invasive Ther Allied Technol; 2018 Dec; 27(6):333-338. PubMed ID: 29475395
[No Abstract] [Full Text] [Related]
13. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
[TBL] [Abstract][Full Text] [Related]
14. Factors Associated with Ureteral Stent Failure in Patients with Malignant Ureteral Obstruction.
Pickersgill NA; Wahba BM; Vetter JM; Cope SJ; Barashi NS; Henning GM; Du K; Figenshau RS; Desai AC; Venkatesh R
J Endourol; 2022 Jun; 36(6):814-818. PubMed ID: 35018790
[No Abstract] [Full Text] [Related]
15. Use of full-length metallic stents in malignant ureteral obstruction.
Abbasi A; Wyre HW; Ogan K
J Endourol; 2013 May; 27(5):640-5. PubMed ID: 23237309
[TBL] [Abstract][Full Text] [Related]
16. The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study.
Miyazaki J; Onozawa M; Takahashi S; Maekawa Y; Yasuda M; Wada K; Maeda Y; Masaki T; Yamaguchi A; Suzuki M; Sakai Y; Kimura T; Takai M; Seike K; Hashimoto T; Yamamoto S
BMC Urol; 2019 Dec; 19(1):137. PubMed ID: 31881875
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Stent Failure for Malignant Ureteral Obstruction in Non-Urological Cancer.
Heo JE; Jeon DY; Lee J; Han HH; Jang WS
Yonsei Med J; 2023 Nov; 64(11):665-669. PubMed ID: 37880847
[TBL] [Abstract][Full Text] [Related]
18. Metallic ureteral stents in malignant ureteral obstruction: short-term results and radiological features predicting stent failure in patients with non-urological malignancies.
Chow PM; Hsu JS; Wang SM; Yu HJ; Pu YS; Liu KL
World J Urol; 2014 Jun; 32(3):729-36. PubMed ID: 23933664
[TBL] [Abstract][Full Text] [Related]
19. The Role of Tandem Double-J Ureteral Stents in the Management of Malignant Ureteral Obstruction.
Varnavas M; Bolgeri M; Mukhtar S; Anson K
J Endourol; 2016 Apr; 30(4):465-8. PubMed ID: 26585189
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for overall survival in malignant ureteral obstruction.
Mason JB; Creswell M; Egan J; Dall C; Sholklapper T; Galloway LA; Orzel J; Lee H; Desale S; Stamatakis L
Can J Urol; 2022 Jun; 29(3):11162-11169. PubMed ID: 35691038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]